Hematology NewsNew single-tube assay detects one CLL cell in 1 million leukocytesApril 27, 2016CLLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsVP Biden to AACR: Help me help youApril 21, 2016Patient & Survivor CarePractice ManagementCLLCMLIndolent LymphomaBusiness of Medicine
Hematology NewsIn newly diagnosed CLL, mutation tests are advisedApril 13, 2016CLLCMLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDG-PET guides need for eBEACOPP in advanced Hodgkin’sApril 12, 2016Indolent LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsCUDC-907 enters phase II for relapsed or refractory lymphoma and multiple myelomaApril 12, 2016Indolent LymphomaTranslational ResearchLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsFDA approves venetoclax for CLL with 17p deletionApril 11, 2016Indolent LymphomaLeukemia, Myelodysplasia, TransplantationCLL
Hematology NewsOTX015 dose for lymphoma narrowed in phase 1 studyApril 10, 2016Indolent LymphomaAggressive LymphomasMultiple MyelomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsFeds advance cancer moonshot with expert panel, outline of goalsApril 5, 2016CMLCLLIndolent LymphomaMultiple MyelomaBreast CancerGenitourinary CancerGynecologic Cancer
Hematology NewsIdelalisib use halted in six combo therapy trials, FDA announcesMarch 15, 2016Indolent LymphomaCLLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsFollicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvementMarch 10, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsExpert panel issues guidelines for treatment of hematologic cancers in pregnancyDecember 1, 2015CMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive LymphomasAMLIndolent Lymphoma
Hematology NewsNew therapies finding their place in management of follicular lymphomaNovember 5, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsMedical Roundtable: Hodgkin Lymphoma - Discussing Recent Evidence & Practice OptionsOctober 19, 2015Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
Hematology NewsObinutuzumab trends better than rituxumab in relapsed indolent lymphomaSeptember 3, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsLenalidomide + rituximab combo effective in recurrent follicular lymphomaAugust 24, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
